Cadila hits 52-week low on 14 observations from USFDA for Moraiya plant

The US Food and Drug Administration has issued 14 observations after inspecting the drug firm's manufacturing facility at Moraiya in Ahmedabad.

from Latest News http://bit.ly/2Vf2obE
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share